What We Can Learn from HIV in Communicating about COVID-19 May 6, 2020 Blog As we navigate how to communicate about COVID-19 and the urgent public health issues it brings, there is much that can be learned in looking at HIV messaging and how it has evolved. This blog discusses some of our observations from KFF’s more than two decades of experience running large-scale public information campaigns about HIV and other communicable diseases that have bearing in this new environment.
State Medicaid Management of Prescription Drugs for HIV Treatment and Prevention June 4, 2020 Issue Brief This data note, primarily based on a survey of state Medicaid pharmacies, reviews cost-containment policies and protections as they relate to antiretrovirals for treatment and prevention of HIV.
Key Questions: HIV and COVID-19 May 20, 2021 Issue Brief This brief examines and summarizes what we know about COVID-19 and HIV including, what we know about COVID-19 risk, disease severity, vaccination, and federal response. It also explores how people with HIV are overly represented in many of the demographic groups hardest hit by the pandemic.
Ryan White Funding Relatively Flat for More Than a Decade While Share of People Living With HIV Has Grown February 19, 2019 Slide For more than a decade, funding for the Ryan White Program has remained relatively flat while the share of people living with HIV has grown. Learn more in this Chart of the Week.
Centers for Disease Control and Prevention (CDC) HIV Prevention Funding, 1981-2019 February 14, 2019 Slide